Literature DB >> 11750376

Absence of acute rejection using basiliximab with triple immunosuppression in cadaveric kidney recipients in first three months.

A Kandus1, D Kovac, J Buturović-Ponikvar, R Ponikvar, M Koselj, J Lindic, A Kmetec, A F Bren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11750376     DOI： 10.1016/s0041-1345(01)02365-x

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  1 in total

Review 1.  Basiliximab: a review of its use as induction therapy in renal transplantation.

Authors:  Therese M Chapman; Gillian M Keating
Journal:  Drugs       Date:  2003       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.